ALKEM LABS LTD FDA Approval ANDA 207623

ANDA 207623

ALKEM LABS LTD

FDA Drug Application

Application #207623

Application Sponsors

ANDA 207623ALKEM LABS LTD

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL20MG/ML0PREGABALINPREGABALIN

FDA Submissions

UNKNOWN; ORIG1AP2019-07-19STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207623
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"PREGABALIN","activeIngredients":"PREGABALIN","strength":"20MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/19\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-07-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.